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ABSTRACT: Introduction: Clinicians often assume that observa-
tions of pain behavior are adequate for assessment of patient
pain perception during procedures. This has not been tested
during a standardized electrodiagnostic experience. Methods:
During a prospective trial including extensive, standardized
electrodiagnostic testing on persons with lumbar stenosis, vas-
cular claudication, and asymptomatic volunteers, the subjects
and an observer rated levels of pain. Results: In 60 subjects,
observers significantly under-rated pain (Visual Analog Scale
3.1762.23 vs. 4.386 2.01, t524.577, df5 59, P<0.001).
Perceived pain during testing related to bodily pain as meas-
ured by the visual analog, McGill, Pain Disability, and Quebec
scales, but not age, duration of symptoms, Tampa kinesiphobia,
Center for Epidemiological Studies Depression scale, or SF-36
health quality of life. Conclusions: Persons with worse pain syn-
dromes may perceive more pain during testing than others.
Clinicians and researchers should understand that patients may
have more pain than they recognize.
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The needle insertions and electrical stimulations
performed during electrodiagnostic (EDx) testing
provide important clinical information and are fre-
quently tolerated well by patients. However they
are undeniably painful, and it is thus important to
understand and diminish pain when possible.
Several studies have examined factors that pre-
dict pain. For example it appears that pain percep-
tion before testing also relates to the pain
experience.1 Most,1–3 but not all4 studies suggest
that women perceive a greater level of pain during
EDx. However, other possible predictors do not
relate to pain during testing. Gans and Kraft2
found no correlation between the pain of the
exam and race, level of education, anxiety level,
number of areas tested, or characteristics of the
examiner. This literature hints at risk factors for
suffering during testing. However, the results have
low predictive value and are of limited practical
use in the laboratory.
During individual testing, compassionate physi-
cians will often seek to understand the level of
pain their patients are experiencing. They can
observe pain behavior or ask the patients to rate
their pain. The latter may seem awkward, because
some may fear that discussing pain can increase
the pain experience. Some also may think that a
discussion about pain could take time and thus
decrease efficiency. However, if simple observation
does not assess adequately the level of distress it
may be necessary to ask patients about their pain.
The validity of observation of pain experience ver-
sus perceived pain during EDx testing requires
examination.
An excellent opportunity to examine the rela-
tionship between perceived and observed pain
occurred as part of a prospective research study
performed for other reasons. Aspects of that study
that were useful for addressing the current ques-
tion include an extensive EDx protocol which was
the same for all subjects and extensive characteri-
zation of subjects in terms of pain, disability, emo-
tional status, and masked physical examination.
Finally, both persons with painful disorders (neu-
rogenic and vascular claudication) and asymptom-
atic volunteers were tested.
The main hypothesis for this study is that, dur-
ing EDx testing the pain levels judged by an out-
side observer relate to the pain reported by the
person undergoing the test. Several additional
questions were addressed. What is the level of pain
experienced during EDx testing by persons who
have no disease? Is the pain experienced by an
asymptomatic volunteer different than the pain
experienced by subjects with neurogenic claudica-
tion and subjects with vascular claudication? What
factors relate to self-reported pain level during
testing?
METHODS
As part of a study intended to compare EDx
and imaging studies in the diagnosis of spinal
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disorders, 2 groups of persons aged 55–90 were
recruited from review of university clinic records.
One included persons with lumbar spinal stenosis
and neurogenic claudication sufficiently severe
that they were offered surgery by university faculty
spine surgeons, and another included persons with
vascular claudication and positive ankle-brachial
index. A third group of asymptomatic volunteers
aged 55–90 was gathered from postings in the
community.
For the purposes of the larger study several
exclusions were applied. Through review of medi-
cal records and interviews, potential subjects were
excluded from the study if they had previous back
surgery, cardiopulmonary precautions for ambula-
tion testing, or (except for the vascular group, who
could have diabetes) risk factors for neuromuscu-
lar disease (diabetes, alcohol more than 12 drinks
per week, personal or family history of neuromus-
cular disease, or history of previous significant
focal lower limb nerve injury). Contraindications
to MRI scanning (metal, obesity, unmanageable
claustrophobia), relative contraindications or tech-
nical issues related to EDx testing (previous lum-
bar surgery, warfarin therapy, severe immune
disorder, extreme obesity, 31 or greater pitting
edema, or implanted electrodes such as defibrilla-
tors), were exclusions. Among the groups with the
recruitment diagnoses of neurogenic or vascular
claudication, anyone who had another disorder
that, in the investigator’s opinion, might limit
ambulation more than the vascular or neurogenic
claudication were eliminated. Ankle-brachial index
was performed on all subjects, and any subject with
discordant ankle brachial index (abnormal in ste-
nosis or asymptomatic persons; normal in vascular
claudication subjects) was eliminated. Subjects
were required to be competent and willing to
travel to the testing appointments at their own
expense. All subjects were compensated for their
efforts. The study was approved by the university’s
ethical review board, and all subjects provided writ-
ten informed consent for participation in the
study.
The final cohorts also underwent other testing.
This included the lengthy standard university spine
program questionnaire with demographic, medical,
social, family, and spine history, and an extensive
review of systems. Standardized measures analyzed
in this study included a 10 cm visual analog scale
for pain,5 the Pain Disability Index,6 the McGill
Pain Scale,7 and the Quebec Back Pain Disability
Scale.8 Other validated scales administered
included the Swiss Stenosis Questionnaire,9 the
Walking Impairment Questionnaire,10 the Multidi-
mensional Pain Inventory,11 and the SF-36.12
Before EDx testing, 1 of 3 faculty neurosurgeons
and a single vascular surgeon performed a compre-
hensive spine and vascular history and physical
examination. Subjects underwent MRI scanning
unless it had been done previously for stenosis.
Perceived level of pain was rated by the subjects
immediately after testing without consultation with
the observers. Observed level of pain was observed
by research assistants (not the physicians who were
performing the tests) during EDx testing and was
recorded immediately after the test was completed
without consultation with the patient or physician
tester. The research assistants were college gradu-
ates in health science related fields, but they were
not experienced clinicians. They received special
training in the research protocol, including the
need to observe pain behavior, however no special
instruction on observation or interpretation of
physical signs of pain was given. The assistants
were familiar with the subjects through at least an
hour of personal interaction, including the obtain-
ing of informed consent, assisting with and collect-
ing surveys, performing standardized walking tests,
and in most cases observing the subject during the
surgeon’s exams. Before EDx testing, the assistants
coached the subjects on ways to keep the EDx phy-
sician masked. The subjects were allowed to voice
discomfort related to the test, but if they experi-
enced pain related to their diagnosis (e.g., back
pain in a spinal stenosis subject) they were to tell
the assistant, and the EDx physician was to leave
the room while adjustments were made.
Pain was experienced through a standardized
EDx protocol included paraspinal mapping, which
involves insertion of a 50–75 mm monopolar elec-
tromyography needle into 12 locations on each
side.13 Needle examination included examination
of 6 muscles in 1 limb, with 6 insertions in 4 direc-
tions and mild muscle contraction with the needle
in the muscle for observation of motor unit poten-
tial recruitment. The muscles examined were the
gluteus maximus, tensor fascia lata, vastus medialis,
fibularis longus, anterior tibialis, and medial gas-
trocnemius. Nerve conduction studies included
bilateral tibial H-reflexes, and unilateral sural sen-
sory and fibular motor (ankle, fibular head, and
popliteal stimulation) conduction. Occasionally a
patient with unusual findings suggesting polyneu-
ropathy underwent additional nerve conduction
studies. In these cases the protocol included the
possibility of an ulnar sensory nerve action poten-
tial, ulnar compound muscle action potential, and
needle exam of the first dorsal interosseous of the
hand.
The testing (not the observation of pain) was
performed by an American Board of Electrodiag-
nostic Medicine certified physiatrist or neurologist
trained in the study protocol. The EDx physician
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was allowed to greet subjects and make them at
ease during testing. He or she was not allowed to
ask about any spine or vascular symptoms and was
discouraged from idle conversation that might
result in unmasking. However, he or she could
observe and ask about pain during testing and
could provide reassurance or adjustment for pain.
Statistical Analysis. PASW Statistics 18 (SPSS Inc.,
Chicago, Illinois) was used for data analysis. A t-
test for two-group comparisons and analysis of var-
iance (ANOVA) for differences among 3 or more
groups were used for continuous measures. A
paired-sample t-test was used to compare ratings of
observed and perceived pain by the observers. Chi-
square tests were conducted to examine the rela-
tionship between categorical variables, for exam-
ple, subjects’ gender or race versus subject
grouping. A Pearson correlation analysis was used
to assess the relationship between 2 continuous
variables. A P-value of <0.05 was considered signifi-
cant in all analyses.
RESULTS
The population of the study comprised 60 per-
sons, 55.0% men and 85.0% white with a mean
age of 63.76 7.9 years. The study included 3
groups of individuals: (1) asymptomatic commu-
nity volunteers (n5 25; 41.7%), (2) patients who
had a diagnosis of vascular claudication (n5 7;
11.7%), and (3) patients who were diagnosed to
have neurogenic claudication (n5 28; 46.7%) (see
Table 1).
Table 2 lists pain, psychological, functional,
and quality of life variables. More detailed compar-
ison between the 3 subject groups found no demo-
graphic differences except in education level (F5
3.552; P5 0.036), with asymptomatic volunteers
being more educated than others. As expected,
and not reported in detail here, highly significant
(P< 0.001) differences between the diagnostic
groups were found for the visual analog pain scale,
McGill, Quebec, Tampa, Center for Epidemiologi-
cal Studies Depression scale, Pain Disability Index,
and all SF-36 categories except general health
(P5 0.018) and general mental health (P5 0.156).
More stenosis subjects (32.1%) had abnormal
(greater than 4) paraspinal mapping electromyog-
raphy scores than vascular (14.3%) or asymptom-
atic volunteers (16.7%), Despite the apparent
sizable clinical difference in these groups, the asso-
ciation between the 2 groups and paraspinal map-
ping scores was not significant. Chi Squared
value5 2.085, P5 0.149.
Table 3 lists the relationship between subject
variables and pain. There was no relationship
between volunteer status and pain. (Perceived pain
F5 0.816, P5 0.447, observed pain F50.038, P5
0.963, ratio perceived/observed pain F5 0.0991,
P5 0.377). Persons with normal strength on exam-
ination perceived but did not display more pain
than others. This was not true of other objective
neurological signs or of tenderness to palpation.
No aspect of the vascular surgeon’s examination
related to observed or perceived pain.
Observers underrated the observed pain (3.176
2.23) subjects experienced in comparison to the
level of pain subjects reported (4.386 2.01) on a 0–
10 scale (t524.577, df5 59, P< 0.001). The pain
ratio (calculated as observed pain/perceived pain)
measured 0.786 0.47, as displayed in Figure 1.
Table 4 analyzes variables that may contribute
statistically to perceived pain. There was a
Table 1. Demographic characteristics of the 3 study groups.
Demographics All subjects (n 5 60)
Neurogenic claudication 28
Vascular claudication 7
Asymptomatic 25
Age, years 63.7 6 7.9
Gender
Men 33 (55.0%)
Women 27 (45.0%)
Race
White 51 (85.0%)
Non-white 9 (15.0%)
Marital status
Married 37 (61.7%)
Not married 23 (38.3%)
Working status
Working 21 (35.6%)
Not working 38 (64.4%)
Education, years 14.7 6 2.9
BMI, weight (kg) / height (m2) 30.4 6 5.9
Table 2. Population pain, function, psychological
and quality of life.
Parameter All subjects (n 5 60)
Pain variables
Average weekly pain (visual analog in cm.) 2.7 6 3.0
McGill total 15.1 6 16.6
Quebec Back Pain Disability Scale 27.6 6 26.5
Psychological characteristics
Tampa somatic 10.0 6 3.4
Tampa avoidance 16.9 6 5.6
CESD Depression 8.5 6 8.7
Functional status
Pain Disability Index 16.6 6 17.8
SF 36
General Health 69.3 6 18.8
Physical Functioning 57.2 6 31.5
Social Functioning 80.0 6 24.7
Role Limit.- Physical 54.7 6 43.5
Role Limit.- Emotional 82.2 6 33.2
General Mental Health 79.5 6 16.7
Vitality (VT) Energy/Fatigue 59.6 6 22.0
Bodily Pain 60.0 6 28.1
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significant association between the perceived pain
with the McGill Pain Index (r5 .288, P5 0.026),
Pain Disability Index (r5 .314, P5 0.014), and
Quebec Back Pain Disability Scale (r5 .290,
P5 0.030). The perceived pain however, was not
found to be significantly (P> 0.05) related to age
and duration of the problem, visual analog scale
rating of the subjects’ back and leg pain com-
plaint, Tampa fear of movement / (re)injury, or
Center for Epidemiologic Studies Depression
Scale. Neither the perceived pain nor observed
pain were found to be correlated with each of the
8 domains of the SF-36 (measuring physical func-
tioning, role limitations due to physical health,
bodily pain, general health perceptions, vitality,
social functioning, role limitations due to emo-
tional problems, and mental health).
DISCUSSION
This study provided a unique opportunity to
understand pain perception and pain behavior in
response to a controlled but realistic clinical stimu-
lus. Although the study methodology has some lim-
its, the findings may help electrodiagnosticians
better understand their patients’ experiences. The
results also provide some information on pain
behavior versus perception that may enlighten
pain scientists.
One strength of the experimental design is the
nature of the pain stimulus. The EDx was a real clini-
cal experience in a real clinical setting. The testing,
and thus the extent of tissue stimulation was highly
standardized and rather extensive. Pain perception
may have been affected by efforts of the electrodiag-
nosticians to comfort subjects, and this was not con-
trolled. Likewise the observers, although trained
research assistants, were not masked and were not
clinicians. Thus, the results may not reflect how the
EDx clinician would have rated the subjects’ pain
level. However, after spending some time with the
subjects during other parts of the test, the observers
were more personally familiar with the subjects than
many EDx clinicians would be.
Previous literature informs us about the pain
experience of persons who undergo EDx. However
Table 3. The relationship between clinical findings and pain variables.
Clinical finding
Perceived pain Observed pain
Perceived pain /
observed pain
Rating t-test (P)* Rating t-test (P)* Ratio t-test (P)*
Neurogenic N528 4.9 6 2.0 3.3 6 2.1 0.7 6 0.4 3.518 (.001)
Vascular N57 3.8 6 2.2 3.1 6 2.0 1.0 6 0.7 0.738 (.244)
Asymptomatic N525 4.2 6 1.9 3.1 6 2.5 0.7 6 0.5 2.958 (.0035)
EMG (symptomatic side)
Negative (n545) (score<5 4) 4.3 6 2.1 20.532 (.597) 3.0 6 2.0 20.919 (.362) 0.8 6 0.5 0.496 (.622)
Positive (n514) (score>4) 4.6 6 1.7 3.6 6 2.8 0.7 6 0.5
Neurosurgeon exam
Strength
Normal (n549) 4.1 6 1.9 22.495 (.016)* 3.1 6 2.2 20.075 (.941) 0.8 6 0.4 1.663 (.102)
Abnormal (n55) 6.4 6 2.1 3.2 6 2.3 0.5 6 0.2
Reflex
Normal (n531) 4.1 6 2.0 20.810 (.421) 3.4 6 2.5 20.876 (.385) 0.9 6 0.5 1.738 (.088)
Abnormal (n523) 4.6 6 2.1 2.8 6 2.1 0.7 6 0.3
Great toe sensation
Normal (n553) 4.3 6 2.1 3.1 6 2.2 * 0.7 6 0.4 *
Abnormal (n51) 3.0 4.0 1.3
Lumbar tenderness
Normal (n551) 4.3 6 2.1 * 3.0 6 2.1 * 0.8 6 0.4 *
Abnormal (n53) 4.7 6 1.5 5.0 6 3.6 1.0 6 0.4
*ANOVA test for all unless indicated otherwise.
FIGURE 1. The relationship between perceived pain and
observed pain behavior during EDx testing.
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most of these studies did not standardize the stim-
ulus (e.g., number and location of needle inser-
tions). Very little previous work has compared
observation of pain during testing to experienced
pain.
One important exception includes a study
which included some of the authors of the current
study but involved a different population with
different methods.14 In that study, clinical EDx
physicians who performed testing tended to overes-
timate patient pain and limited their testing when
they perceived that the patient had greater pain. It
is worthwhile to contrast these studies. In the other
study, the EDx physician had a sense of responsi-
bility to the patient. The amount of pain the
patient experienced was linked directly to the EDx
physician’s actions, so a sense of empathy may lead
to greater sensitivity to indications of patient pain
than an observer. Neither the EDx physician nor
the patient was blinded to the purpose of the
study. Thus, the EDx physicians knew that the
results of the study would reflect on their concern
for their patients’ well-being. Observers, on the
other hand, have no reason to be dishonest, even
subconsciously. Patients give both verbal and non-
verbal clues that they are in pain, and EDx physi-
cians may miss the nonverbal cues because their
eyes are on the computer screen after the elec-
trode is inserted. Observers, on the other hand,
can watch and listen to the patient. Finally, EDx
physicians are more experienced than observers in
assessing pain. This experience may translate to a
different interpretation of patient pain.
The result of this study showed that asymptom-
atic volunteers rated the extensive protocol as
moderately painful (4.26 1.9 cm on a visual ana-
log pain scale). This information can be useful to
ethical review boards and scientists as they weigh
the risk-benefit ratio of EDx in research. Most stud-
ies would not be as extensive or painful as this
one. The fact that the neurogenic and vascular
claudication subjects (who undergo the test with a
possibility of clinical consequences), experienced
pain at the same level as asymptomatic volunteers
supports further extrapolation of the pain levels of
volunteers to those of people with disease. This
may be helpful to scientists who study other pain-
ful procedures.
There was a significant relationship between
subjects’ perceived pain during EDx testing and
their response to self-reported pain and disability
during daily life and to psychosocial factors. It
appears that people who rate their disease-related
pain and disability higher also rate their test-
related pain higher. One can speculate as to
whether the disease state caused increased
sensitivity to test-related pain, or whether these
people are predisposed to be more sensitive to
pain.
Because expectations of pain influence anxiety
levels,15,16 one might hypothesize that asymptom-
atic volunteers, with little personal stake in the
results of the test, would have less pain. However
volunteer status (asymptomatic, vascular claudica-
tion, or neurogenic claudication) did not relate to
the level of perceived pain. Perhaps those who
choose to participate in a study, whether sympto-
matic or asymptomatic, may differ in pain aversion
or pain expression than others. More likely the
experience and perception of research volunteers
is not much different from that of patients.
There is a significant gap in pain ratings
between the subjects’ report and the observers’
assessment. This revelation suggests that electro-
diagnosticians may misunderstand and under-
estimate the pain their patients experience. Clini-
cians who understand that their patients may be
suffering more than they think can take action.
The measurement of pain by nonclinician
observers has positives and negatives that are not
clearly delineated in the literature. In a Medline
search of 460 articles gleaned through a search of
“pain measurement” and “inter-observer measure-
ment, we could find no article that compares the
competency of clinicians versus unrelated
untrained observers in rating the pain of other
persons. Certainly it makes sense that mothers
score their children’s pain differently than clini-
cians.17 There are also known biases among lay
observers. For example, lay observers tend to rate
the pain women experience as less than that expe-
rienced by men.18 However, any assumption about
the validity of observers versus trained physicians is
not borne out in the literature that we could find.
Possible assumptions might be that clinicians are
more expert in interpreting pain behavior. Alterna-
tively, clinicians may be hardened to the pain of
patients, because they are exposed to so much
pain compared with usual life experience. Clini-
cians may also be too busy during the procedure
to notice pain behavior. It seems unlikely that non-
clinician observers would be more calloused in
their ratings of pain than clinicians. If that is true,
then this methodology represents increased com-
passion compared with clinician observation. Even
in this case, the observer under-rates pain com-
pared with the patient.
These findings are consistent with the literature
on patient and physician ratings of pain through-
out the clinical interaction. Physicians underesti-
mate the pain patients experience as a result of
diseases ranging from gout to acute abdomen.19 As
in this study, they underestimate the pain patients
experience in procedures including bone marrow
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biopsy and lymph node resection.20–22 They over-
estimate the pain effect of treatments such as acu-
puncture by as much as 80%.23
Several studies over the last 50 years have sug-
gested ways to make the EDx experience less
uncomfortable. Ibuprofen reduces immediate per-
ception of pain, but not memory of pain later.24
Several studies have studied the contention that
monopolar needles hurt less.25,26 The needle tech-
nique used matters.4 Topical anesthetics27 and jet-
injected lidocaine28 have been shown to help,
while acupuncture29 has not. Behavior modifica-
tion and relaxation techniques are thought to
help.30 Premedication can help, but it is not used
frequently due to the long-term side-effects.31
Informed patients usually choose to complete
this somewhat painful test in the hope that it will
reveal useful information about their condition.
However, clinicians who find patients are not com-
fortable during testing might try to make them
more comfortable by providing reassurance, taking
a break, or developing a strategy to minimize test-
ing; the clinician should ask the patient rather than
simply observing pain behavior.
An important limitation of this work is its lin-
ear, quantitative approach. This study and others
that describe findings as means and standard devi-
ations cannot accurately describe the myriad fac-
tors, often sequential rather than additive, that
truly explain the pain experience of a patient. A
more modern approach to methodology, action
research methodology, can result in case-law logic
in which experts outline certain factors that they
believe relate to pain or pain relief and the steps
taken to relieve pain in those circumstances. An
increasingly complex model can be implemented
as a checklist or flowchart. Where the model is
believed to represent a sufficient percentage of
experiences in the EDx lab it can be researched
as a “black box” intervention to randomized con-
trolled trials. It can be reproduced and taught. If
subsequent research on pain in EDx is going to
impact the pain experience of most patients
meaningfully, it should examine the nonlinear
logic that leads to these kinds of nonreductionist
solutions
In conclusion, asymptomatic volunteers and
persons with disease both experience moderate
pain during this type of extensive EDx testing. The
level of pain experienced is related to pain and
disability they perceive from their disease. Observ-
ers appear to rate the pain of persons undergoing
EDx lower than the persons being tested do. From
a practical standpoint, EDx physicians should
assume that patients experience more pain than
they observe and use intelligent interventions to
detect and manage pain.
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